Clinical Trial Update: To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED) [Phase 3]

View source ↗

Summary

A Phase 3 trial assessed the lipid-lowering effects of combining ezetimibe/simvastatin with extended-release niacin in patients with Type IIa or IIb hyperlipide…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Hypercholesterolemia
• Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• Niacin Extended Release Tablet (niacin)
• ezetimibe/simvastatin (ezetimibe/simvastatin)

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED | Results posted: 2009-08-03